nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—SLC15A1—Lisinopril—systemic scleroderma	0.206	0.266	CbGbCtD
Ceftriaxone—SLC15A1—Captopril—systemic scleroderma	0.154	0.199	CbGbCtD
Ceftriaxone—SLC22A6—Captopril—systemic scleroderma	0.0849	0.11	CbGbCtD
Ceftriaxone—ALB—Captopril—systemic scleroderma	0.0723	0.0934	CbGbCtD
Ceftriaxone—SLC22A11—Methotrexate—systemic scleroderma	0.0662	0.0855	CbGbCtD
Ceftriaxone—ALB—Mycophenolate mofetil—systemic scleroderma	0.0569	0.0736	CbGbCtD
Ceftriaxone—ALB—Prednisone—systemic scleroderma	0.0455	0.0588	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—systemic scleroderma	0.0385	0.0497	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—systemic scleroderma	0.0268	0.0346	CbGbCtD
Ceftriaxone—ALB—Methotrexate—systemic scleroderma	0.0228	0.0295	CbGbCtD
Ceftriaxone—Pruritus—Pentoxifylline—systemic scleroderma	0.000398	0.00176	CcSEcCtD
Ceftriaxone—Anaemia—Leflunomide—systemic scleroderma	0.000398	0.00176	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000397	0.00176	CcSEcCtD
Ceftriaxone—Vaginal infection—Methotrexate—systemic scleroderma	0.000397	0.00176	CcSEcCtD
Ceftriaxone—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00175	CcSEcCtD
Ceftriaxone—Flushing—Lisinopril—systemic scleroderma	0.000395	0.00175	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000395	0.00175	CcSEcCtD
Ceftriaxone—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.000392	0.00173	CcSEcCtD
Ceftriaxone—Malaise—Leflunomide—systemic scleroderma	0.000389	0.00172	CcSEcCtD
Ceftriaxone—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000387	0.00171	CcSEcCtD
Ceftriaxone—Leukopenia—Leflunomide—systemic scleroderma	0.000386	0.00171	CcSEcCtD
Ceftriaxone—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000385	0.0017	CcSEcCtD
Ceftriaxone—Abdominal pain—Mometasone—systemic scleroderma	0.000384	0.0017	CcSEcCtD
Ceftriaxone—Body temperature increased—Mometasone—systemic scleroderma	0.000384	0.0017	CcSEcCtD
Ceftriaxone—Discomfort—Azathioprine—systemic scleroderma	0.000384	0.0017	CcSEcCtD
Ceftriaxone—Paraesthesia—Captopril—systemic scleroderma	0.000383	0.00169	CcSEcCtD
Ceftriaxone—Chills—Lisinopril—systemic scleroderma	0.000382	0.00169	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000381	0.00169	CcSEcCtD
Ceftriaxone—Palpitations—Leflunomide—systemic scleroderma	0.000381	0.00168	CcSEcCtD
Ceftriaxone—Anaemia—Mycophenolic acid—systemic scleroderma	0.00038	0.00168	CcSEcCtD
Ceftriaxone—Agitation—Mycophenolic acid—systemic scleroderma	0.000378	0.00167	CcSEcCtD
Ceftriaxone—Dyspepsia—Captopril—systemic scleroderma	0.000376	0.00166	CcSEcCtD
Ceftriaxone—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000375	0.00166	CcSEcCtD
Ceftriaxone—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000373	0.00165	CcSEcCtD
Ceftriaxone—Dizziness—Pentoxifylline—systemic scleroderma	0.000372	0.00165	CcSEcCtD
Ceftriaxone—Malaise—Mycophenolic acid—systemic scleroderma	0.000371	0.00164	CcSEcCtD
Ceftriaxone—Infection—Azathioprine—systemic scleroderma	0.00037	0.00164	CcSEcCtD
Ceftriaxone—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000368	0.00163	CcSEcCtD
Ceftriaxone—Flatulence—Lisinopril—systemic scleroderma	0.000365	0.00161	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000365	0.00161	CcSEcCtD
Ceftriaxone—Palpitations—Mycophenolic acid—systemic scleroderma	0.000363	0.00161	CcSEcCtD
Ceftriaxone—Dysgeusia—Lisinopril—systemic scleroderma	0.000363	0.0016	CcSEcCtD
Ceftriaxone—Discomfort—Leflunomide—systemic scleroderma	0.000362	0.0016	CcSEcCtD
Ceftriaxone—Vomiting—Pentoxifylline—systemic scleroderma	0.000358	0.00158	CcSEcCtD
Ceftriaxone—Convulsion—Mycophenolic acid—systemic scleroderma	0.000356	0.00158	CcSEcCtD
Ceftriaxone—Rash—Pentoxifylline—systemic scleroderma	0.000355	0.00157	CcSEcCtD
Ceftriaxone—Dermatitis—Pentoxifylline—systemic scleroderma	0.000355	0.00157	CcSEcCtD
Ceftriaxone—Headache—Pentoxifylline—systemic scleroderma	0.000353	0.00156	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Methotrexate—systemic scleroderma	0.000352	0.00156	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000352	0.00156	CcSEcCtD
Ceftriaxone—Feeling abnormal—Captopril—systemic scleroderma	0.000352	0.00156	CcSEcCtD
Ceftriaxone—Infection—Leflunomide—systemic scleroderma	0.000349	0.00155	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Captopril—systemic scleroderma	0.000349	0.00154	CcSEcCtD
Ceftriaxone—Discomfort—Mycophenolic acid—systemic scleroderma	0.000346	0.00153	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000344	0.00152	CcSEcCtD
Ceftriaxone—Pruritus—Mometasone—systemic scleroderma	0.000344	0.00152	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000344	0.00152	CcSEcCtD
Ceftriaxone—Anaemia—Lisinopril—systemic scleroderma	0.000342	0.00151	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00034	0.0015	CcSEcCtD
Ceftriaxone—Body temperature increased—Captopril—systemic scleroderma	0.000337	0.00149	CcSEcCtD
Ceftriaxone—Abdominal pain—Captopril—systemic scleroderma	0.000337	0.00149	CcSEcCtD
Ceftriaxone—Oedema—Mycophenolic acid—systemic scleroderma	0.000335	0.00148	CcSEcCtD
Ceftriaxone—Nausea—Pentoxifylline—systemic scleroderma	0.000334	0.00148	CcSEcCtD
Ceftriaxone—Chills—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00148	CcSEcCtD
Ceftriaxone—Malaise—Lisinopril—systemic scleroderma	0.000334	0.00148	CcSEcCtD
Ceftriaxone—Infection—Mycophenolic acid—systemic scleroderma	0.000333	0.00147	CcSEcCtD
Ceftriaxone—Diarrhoea—Mometasone—systemic scleroderma	0.000332	0.00147	CcSEcCtD
Ceftriaxone—Leukopenia—Lisinopril—systemic scleroderma	0.000331	0.00147	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000328	0.00145	CcSEcCtD
Ceftriaxone—Palpitations—Lisinopril—systemic scleroderma	0.000327	0.00145	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000324	0.00143	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000323	0.00143	CcSEcCtD
Ceftriaxone—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00141	CcSEcCtD
Ceftriaxone—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00141	CcSEcCtD
Ceftriaxone—Paraesthesia—Leflunomide—systemic scleroderma	0.000316	0.0014	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000315	0.00139	CcSEcCtD
Ceftriaxone—Discomfort—Lisinopril—systemic scleroderma	0.000311	0.00138	CcSEcCtD
Ceftriaxone—Dyspepsia—Leflunomide—systemic scleroderma	0.00031	0.00137	CcSEcCtD
Ceftriaxone—Pancreatitis—Prednisone—systemic scleroderma	0.000309	0.00137	CcSEcCtD
Ceftriaxone—Vomiting—Mometasone—systemic scleroderma	0.000309	0.00137	CcSEcCtD
Ceftriaxone—Sweating increased—Prednisone—systemic scleroderma	0.000307	0.00136	CcSEcCtD
Ceftriaxone—Feeling abnormal—Azathioprine—systemic scleroderma	0.000307	0.00136	CcSEcCtD
Ceftriaxone—Rash—Mometasone—systemic scleroderma	0.000306	0.00136	CcSEcCtD
Ceftriaxone—Dermatitis—Mometasone—systemic scleroderma	0.000306	0.00135	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000304	0.00135	CcSEcCtD
Ceftriaxone—Headache—Mometasone—systemic scleroderma	0.000304	0.00135	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000302	0.00134	CcSEcCtD
Ceftriaxone—Oedema—Lisinopril—systemic scleroderma	0.000302	0.00134	CcSEcCtD
Ceftriaxone—Pruritus—Captopril—systemic scleroderma	0.000302	0.00134	CcSEcCtD
Ceftriaxone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000301	0.00133	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00133	CcSEcCtD
Ceftriaxone—Pain—Leflunomide—systemic scleroderma	0.000301	0.00133	CcSEcCtD
Ceftriaxone—Infection—Lisinopril—systemic scleroderma	0.0003	0.00133	CcSEcCtD
Ceftriaxone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.0003	0.00133	CcSEcCtD
Ceftriaxone—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000298	0.00132	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000296	0.00131	CcSEcCtD
Ceftriaxone—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000295	0.00131	CcSEcCtD
Ceftriaxone—Neutropenia—Prednisone—systemic scleroderma	0.000295	0.00131	CcSEcCtD
Ceftriaxone—Body temperature increased—Azathioprine—systemic scleroderma	0.000294	0.0013	CcSEcCtD
Ceftriaxone—Abdominal pain—Azathioprine—systemic scleroderma	0.000294	0.0013	CcSEcCtD
Ceftriaxone—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000293	0.00129	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000292	0.00129	CcSEcCtD
Ceftriaxone—Diarrhoea—Captopril—systemic scleroderma	0.000292	0.00129	CcSEcCtD
Ceftriaxone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00029	0.00128	CcSEcCtD
Ceftriaxone—Feeling abnormal—Leflunomide—systemic scleroderma	0.00029	0.00128	CcSEcCtD
Ceftriaxone—Nausea—Mometasone—systemic scleroderma	0.000289	0.00128	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000288	0.00127	CcSEcCtD
Ceftriaxone—Ataxia—Methotrexate—systemic scleroderma	0.000287	0.00127	CcSEcCtD
Ceftriaxone—Pain—Mycophenolic acid—systemic scleroderma	0.000287	0.00127	CcSEcCtD
Ceftriaxone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00127	CcSEcCtD
Ceftriaxone—Dizziness—Captopril—systemic scleroderma	0.000282	0.00125	CcSEcCtD
Ceftriaxone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000281	0.00124	CcSEcCtD
Ceftriaxone—Urticaria—Leflunomide—systemic scleroderma	0.000279	0.00124	CcSEcCtD
Ceftriaxone—Abdominal pain—Leflunomide—systemic scleroderma	0.000278	0.00123	CcSEcCtD
Ceftriaxone—Body temperature increased—Leflunomide—systemic scleroderma	0.000278	0.00123	CcSEcCtD
Ceftriaxone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000276	0.00122	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000275	0.00122	CcSEcCtD
Ceftriaxone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000274	0.00121	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000274	0.00121	CcSEcCtD
Ceftriaxone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000273	0.00121	CcSEcCtD
Ceftriaxone—Paraesthesia—Lisinopril—systemic scleroderma	0.000271	0.0012	CcSEcCtD
Ceftriaxone—Vomiting—Captopril—systemic scleroderma	0.000271	0.0012	CcSEcCtD
Ceftriaxone—Rash—Captopril—systemic scleroderma	0.000269	0.00119	CcSEcCtD
Ceftriaxone—Dermatitis—Captopril—systemic scleroderma	0.000269	0.00119	CcSEcCtD
Ceftriaxone—Headache—Captopril—systemic scleroderma	0.000267	0.00118	CcSEcCtD
Ceftriaxone—Dyspepsia—Lisinopril—systemic scleroderma	0.000266	0.00118	CcSEcCtD
Ceftriaxone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000265	0.00117	CcSEcCtD
Ceftriaxone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000265	0.00117	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00117	CcSEcCtD
Ceftriaxone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00117	CcSEcCtD
Ceftriaxone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00116	CcSEcCtD
Ceftriaxone—Eosinophilia—Methotrexate—systemic scleroderma	0.000261	0.00116	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00115	CcSEcCtD
Ceftriaxone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000259	0.00115	CcSEcCtD
Ceftriaxone—Pancreatitis—Methotrexate—systemic scleroderma	0.000259	0.00114	CcSEcCtD
Ceftriaxone—Pain—Lisinopril—systemic scleroderma	0.000258	0.00114	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00113	CcSEcCtD
Ceftriaxone—Diarrhoea—Azathioprine—systemic scleroderma	0.000255	0.00113	CcSEcCtD
Ceftriaxone—Haemoglobin—Prednisone—systemic scleroderma	0.000254	0.00112	CcSEcCtD
Ceftriaxone—Nausea—Captopril—systemic scleroderma	0.000253	0.00112	CcSEcCtD
Ceftriaxone—Haemorrhage—Prednisone—systemic scleroderma	0.000253	0.00112	CcSEcCtD
Ceftriaxone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000249	0.0011	CcSEcCtD
Ceftriaxone—Pruritus—Leflunomide—systemic scleroderma	0.000249	0.0011	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000247	0.00109	CcSEcCtD
Ceftriaxone—Neutropenia—Methotrexate—systemic scleroderma	0.000247	0.00109	CcSEcCtD
Ceftriaxone—Dizziness—Azathioprine—systemic scleroderma	0.000246	0.00109	CcSEcCtD
Ceftriaxone—Diarrhoea—Leflunomide—systemic scleroderma	0.000241	0.00106	CcSEcCtD
Ceftriaxone—Urticaria—Lisinopril—systemic scleroderma	0.00024	0.00106	CcSEcCtD
Ceftriaxone—Abdominal pain—Lisinopril—systemic scleroderma	0.000239	0.00106	CcSEcCtD
Ceftriaxone—Body temperature increased—Lisinopril—systemic scleroderma	0.000239	0.00106	CcSEcCtD
Ceftriaxone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000238	0.00105	CcSEcCtD
Ceftriaxone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000237	0.00105	CcSEcCtD
Ceftriaxone—Vomiting—Azathioprine—systemic scleroderma	0.000237	0.00105	CcSEcCtD
Ceftriaxone—Rash—Azathioprine—systemic scleroderma	0.000235	0.00104	CcSEcCtD
Ceftriaxone—Dermatitis—Azathioprine—systemic scleroderma	0.000235	0.00104	CcSEcCtD
Ceftriaxone—Flushing—Prednisone—systemic scleroderma	0.000234	0.00104	CcSEcCtD
Ceftriaxone—Headache—Azathioprine—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Ceftriaxone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Ceftriaxone—Dizziness—Leflunomide—systemic scleroderma	0.000233	0.00103	CcSEcCtD
Ceftriaxone—Renal failure—Methotrexate—systemic scleroderma	0.000231	0.00102	CcSEcCtD
Ceftriaxone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00023	0.00102	CcSEcCtD
Ceftriaxone—Stomatitis—Methotrexate—systemic scleroderma	0.000229	0.00101	CcSEcCtD
Ceftriaxone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000226	0.001	CcSEcCtD
Ceftriaxone—Haematuria—Methotrexate—systemic scleroderma	0.000224	0.000992	CcSEcCtD
Ceftriaxone—Vomiting—Leflunomide—systemic scleroderma	0.000224	0.000989	CcSEcCtD
Ceftriaxone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000223	0.000985	CcSEcCtD
Ceftriaxone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000222	0.000981	CcSEcCtD
Ceftriaxone—Epistaxis—Methotrexate—systemic scleroderma	0.000222	0.000981	CcSEcCtD
Ceftriaxone—Rash—Leflunomide—systemic scleroderma	0.000222	0.000981	CcSEcCtD
Ceftriaxone—Dermatitis—Leflunomide—systemic scleroderma	0.000222	0.00098	CcSEcCtD
Ceftriaxone—Nausea—Azathioprine—systemic scleroderma	0.000221	0.000979	CcSEcCtD
Ceftriaxone—Headache—Leflunomide—systemic scleroderma	0.00022	0.000975	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—systemic scleroderma	0.000219	0.000971	CcSEcCtD
Ceftriaxone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000965	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000958	CcSEcCtD
Ceftriaxone—Pruritus—Lisinopril—systemic scleroderma	0.000214	0.000946	CcSEcCtD
Ceftriaxone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000213	0.000944	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—systemic scleroderma	0.000212	0.000939	CcSEcCtD
Ceftriaxone—Rash—Mycophenolic acid—systemic scleroderma	0.000212	0.000936	CcSEcCtD
Ceftriaxone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000211	0.000935	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—systemic scleroderma	0.000211	0.000934	CcSEcCtD
Ceftriaxone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00021	0.00093	CcSEcCtD
Ceftriaxone—Headache—Mycophenolic acid—systemic scleroderma	0.00021	0.00093	CcSEcCtD
Ceftriaxone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000926	CcSEcCtD
Ceftriaxone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000926	CcSEcCtD
Ceftriaxone—Nausea—Leflunomide—systemic scleroderma	0.000209	0.000924	CcSEcCtD
Ceftriaxone—Diarrhoea—Lisinopril—systemic scleroderma	0.000207	0.000915	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000204	0.000903	CcSEcCtD
Ceftriaxone—Anaemia—Prednisone—systemic scleroderma	0.000203	0.000899	CcSEcCtD
Ceftriaxone—Agitation—Prednisone—systemic scleroderma	0.000202	0.000894	CcSEcCtD
Ceftriaxone—Dizziness—Lisinopril—systemic scleroderma	0.0002	0.000884	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—systemic scleroderma	0.0002	0.000883	CcSEcCtD
Ceftriaxone—Nausea—Mycophenolic acid—systemic scleroderma	0.000199	0.000882	CcSEcCtD
Ceftriaxone—Malaise—Prednisone—systemic scleroderma	0.000198	0.000877	CcSEcCtD
Ceftriaxone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000863	CcSEcCtD
Ceftriaxone—Vomiting—Lisinopril—systemic scleroderma	0.000192	0.00085	CcSEcCtD
Ceftriaxone—Rash—Lisinopril—systemic scleroderma	0.000191	0.000843	CcSEcCtD
Ceftriaxone—Convulsion—Prednisone—systemic scleroderma	0.000191	0.000843	CcSEcCtD
Ceftriaxone—Dermatitis—Lisinopril—systemic scleroderma	0.00019	0.000842	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—systemic scleroderma	0.000189	0.000838	CcSEcCtD
Ceftriaxone—Headache—Lisinopril—systemic scleroderma	0.000189	0.000837	CcSEcCtD
Ceftriaxone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000829	CcSEcCtD
Ceftriaxone—Discomfort—Prednisone—systemic scleroderma	0.000185	0.000818	CcSEcCtD
Ceftriaxone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000801	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—systemic scleroderma	0.00018	0.000796	CcSEcCtD
Ceftriaxone—Nausea—Lisinopril—systemic scleroderma	0.000179	0.000794	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000179	0.000794	CcSEcCtD
Ceftriaxone—Oedema—Prednisone—systemic scleroderma	0.000179	0.000794	CcSEcCtD
Ceftriaxone—Infection—Prednisone—systemic scleroderma	0.000178	0.000789	CcSEcCtD
Ceftriaxone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000775	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000173	0.000768	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000171	0.000754	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—systemic scleroderma	0.00017	0.000751	CcSEcCtD
Ceftriaxone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000745	CcSEcCtD
Ceftriaxone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000739	CcSEcCtD
Ceftriaxone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000738	CcSEcCtD
Ceftriaxone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000734	CcSEcCtD
Ceftriaxone—Malaise—Methotrexate—systemic scleroderma	0.000166	0.000733	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—systemic scleroderma	0.000164	0.000728	CcSEcCtD
Ceftriaxone—Paraesthesia—Prednisone—systemic scleroderma	0.000161	0.000713	CcSEcCtD
Ceftriaxone—Convulsion—Methotrexate—systemic scleroderma	0.000159	0.000704	CcSEcCtD
Ceftriaxone—Dyspepsia—Prednisone—systemic scleroderma	0.000158	0.000699	CcSEcCtD
Ceftriaxone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000696	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—systemic scleroderma	0.000155	0.000684	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00015	0.000664	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—systemic scleroderma	0.000149	0.000659	CcSEcCtD
Ceftriaxone—Feeling abnormal—Prednisone—systemic scleroderma	0.000148	0.000654	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000147	0.00065	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000147	0.000649	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000145	0.000641	CcSEcCtD
Ceftriaxone—Urticaria—Prednisone—systemic scleroderma	0.000143	0.000631	CcSEcCtD
Ceftriaxone—Abdominal pain—Prednisone—systemic scleroderma	0.000142	0.000628	CcSEcCtD
Ceftriaxone—Body temperature increased—Prednisone—systemic scleroderma	0.000142	0.000628	CcSEcCtD
Ceftriaxone—Paraesthesia—Methotrexate—systemic scleroderma	0.000135	0.000596	CcSEcCtD
Ceftriaxone—Hypersensitivity—Prednisone—systemic scleroderma	0.000132	0.000585	CcSEcCtD
Ceftriaxone—Dyspepsia—Methotrexate—systemic scleroderma	0.000132	0.000584	CcSEcCtD
Ceftriaxone—Pain—Methotrexate—systemic scleroderma	0.000128	0.000567	CcSEcCtD
Ceftriaxone—Pruritus—Prednisone—systemic scleroderma	0.000127	0.000562	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000124	0.000547	CcSEcCtD
Ceftriaxone—Diarrhoea—Prednisone—systemic scleroderma	0.000123	0.000543	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000123	0.000543	CcSEcCtD
Ceftriaxone—Urticaria—Methotrexate—systemic scleroderma	0.000119	0.000527	CcSEcCtD
Ceftriaxone—Dizziness—Prednisone—systemic scleroderma	0.000119	0.000525	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—systemic scleroderma	0.000119	0.000525	CcSEcCtD
Ceftriaxone—Body temperature increased—Methotrexate—systemic scleroderma	0.000119	0.000525	CcSEcCtD
Ceftriaxone—Vomiting—Prednisone—systemic scleroderma	0.000114	0.000505	CcSEcCtD
Ceftriaxone—Rash—Prednisone—systemic scleroderma	0.000113	0.000501	CcSEcCtD
Ceftriaxone—Dermatitis—Prednisone—systemic scleroderma	0.000113	0.0005	CcSEcCtD
Ceftriaxone—Headache—Prednisone—systemic scleroderma	0.000112	0.000497	CcSEcCtD
Ceftriaxone—Hypersensitivity—Methotrexate—systemic scleroderma	0.00011	0.000489	CcSEcCtD
Ceftriaxone—Nausea—Prednisone—systemic scleroderma	0.000107	0.000472	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—systemic scleroderma	0.000106	0.000469	CcSEcCtD
Ceftriaxone—Diarrhoea—Methotrexate—systemic scleroderma	0.000103	0.000454	CcSEcCtD
Ceftriaxone—Dizziness—Methotrexate—systemic scleroderma	9.92e-05	0.000439	CcSEcCtD
Ceftriaxone—Vomiting—Methotrexate—systemic scleroderma	9.54e-05	0.000422	CcSEcCtD
Ceftriaxone—Rash—Methotrexate—systemic scleroderma	9.46e-05	0.000418	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—systemic scleroderma	9.45e-05	0.000418	CcSEcCtD
Ceftriaxone—Headache—Methotrexate—systemic scleroderma	9.4e-05	0.000416	CcSEcCtD
Ceftriaxone—Nausea—Methotrexate—systemic scleroderma	8.91e-05	0.000394	CcSEcCtD
